Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy. Journal of Analytical Oncology, [S. l.], v. 3, n. 2, p.  73–78, 2014. DOI: 10.6000/1927-7229.2014.03.02.1. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/216. Acesso em: 15 jun. 2026.